Volume | 554,921 |
|
|||||
News | - | ||||||
Day High | 202.92 | Low High |
|||||
Day Low | 199.68 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Laboratory Corporation of America Holdings | LH | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
201.12 | 199.68 | 202.92 | 201.32 | 200.25 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
17,522 | 554,921 | $ 201.12 | $ 111,605,567 | - | 195.01 - 243.30 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:00:00 | 65,993 | $ 201.32 | USD |
Laboratory Corporation o... (LH) Options Flow Summary
Laboratory Corporation of America Holdings Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
16.94B | 84.10M | - | 12.16B | 418M | 4.97 | 40.52 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Laboratory Corporation o... News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LH Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 197.08 | 207.535 | 197.01 | 201.48 | 920,265 | 4.24 | 2.15% |
1 Month | 211.00 | 212.685 | 196.11 | 203.49 | 854,700 | -9.68 | -4.59% |
3 Months | 222.73 | 229.46 | 196.11 | 211.35 | 813,555 | -21.41 | -9.61% |
6 Months | 207.84 | 234.09 | 196.11 | 215.26 | 762,344 | -6.52 | -3.14% |
1 Year | 227.97 | 243.30 | 195.01 | 213.68 | 752,508 | -26.65 | -11.69% |
3 Years | 268.00 | 317.17 | 195.01 | 242.84 | 730,836 | -66.68 | -24.88% |
5 Years | 166.30 | 317.17 | 98.02 | 218.01 | 739,288 | 35.02 | 21.06% |
Laboratory Corporation o... Description
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing. With the addition of Covance, LabCorp also has a sizable footprint in the global contract research organization market. |